semaglutide tirzepatide conversion Switching from to dosage chart: complete guide semaglutide to tirzepatide conversion chart

Single cell isolation of bacteria from microbial fuel cells and Potomac river sediment

Key points: In the only head-to-head trial, Wegovy produced 15.8% weight loss compared with 6.4% for Saxenda over the same 68-week period Wegovy 7.2 mg (approved January 2026) produces even greater results at 20.7% average weight loss Real-world data from Second Nature shows 19.1% weight loss with semaglutide when combined with behavioural support Semaglutide participants were nearly three times more likely to achieve at least 10% weight loss than liraglutide participants Side effects and tolerability Both medications share a similar side-effect profile, predominantly affecting the gastrointestinal tract

GLP-1 Pharmacology Glucagon-like peptide 1 agonists simulate the action of incretin, which is a hormone produced by the small intestines, that bind to the GLP-1 receptor

These dietary modifications typically show benefit within 3 to 5 days

Frequently Asked Questions Is there a definitive rule about donating blood while on GLP-1 medications

People who are pregnant should not use liraglutide for weight loss